Citigroup’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-3,035
| Closed | -$74K | – | 7818 |
|
|
2017
Q4 | $74K | Buy |
+3,035
| New | +$58.3K | ﹤0.01% | 5895 |
|
|
2017
Q3 | – | Sell |
-81
| Closed | -$1K | – | 7605 |
|
|
2017
Q2 | $1K | Sell |
81
-268
| -77% | -$3.73K | ﹤0.01% | 7293 |
|
|
2017
Q1 | $5K | Sell |
349
-4,762
| -93% | -$76.5K | ﹤0.01% | 6835 |
|
|
2016
Q4 | $97K | Buy |
5,111
+4,452
| +676% | +$85.4K | ﹤0.01% | 5796 |
|
|
2016
Q3 | $15K | Buy |
+659
| New | +$12.4K | ﹤0.01% | 6372 |
|
|
2016
Q2 | – | Sell |
-3,823
| Closed | -$70K | – | 7704 |
|
|
2016
Q1 | $70K | Buy |
3,823
+3,822
| +382,200% | +$61.8K | ﹤0.01% | 5918 |
|
|
2015
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 8078 |
|
|
2015
Q3 | $0 | Sell |
1
-69
| -99% | -$1.54K | ﹤0.01% | 8020 |
|
|
2015
Q2 | $2K | Sell |
70
-1,495
| -96% | -$37.8K | ﹤0.01% | 7203 |
|
|
2015
Q1 | $35K | Buy |
+1,565
| New | +$33.8K | ﹤0.01% | 5760 |
|
Citigroup's ENTL Position: Q1 2018 in Review
Citigroup sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 3,035 shares — an estimated $74K sold.
Citigroup first reported a position in ENTL in Q1 2015 and held it in 10 quarters. The position peaked at $97K in Q4 2016. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.
- Citigroup reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
- Citigroup sold 3,035 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $74K.
- Citigroup first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 10 quarters.
- Citigroup's Entellus Medical, Inc. Common Stock position peaked at $97K in Q4 2016.
- 0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.
Based on Citigroup's 13F filing for Q1 2018, filed 11 May 2018.